QR Pharma Awarded Funding by Michael J. Fox Foundation to Test Posiphen® as a Treatment for Parkinson’s Disease

Maria Maccecchini to Receive 2011 Iris Newmann Award – November 16, 2011

Maria Maccecchini to Receive 2011 Iris Newmann Award – November 16, 2011  Article >>>>>

QR Pharma Reports Results from SBIR Grant by NIA/NIH to Study Posiphen® and Metabolites in Various Models

QR Pharma to Present Poster at International Conference on Alzheimer’s Disease

QR Pharma to Present at 10th Annual World Pharma Congress on Parkinson’s Disease

QR Pharma to Present at 2nd Annual World Congress of NeuroTalk

QR Pharma to Present at BIO-Windhover Conference /Pharmaceutical Strategic Outlook 2011

Jeffrey Cummings, Rachelle Doody, Martin Farlow and Mary Sano to Form QR Pharma’s Medical Advisory Board

QR Pharma to Present at the 44th Winter Conference on Brain Research

QR Pharma receives FDA clearance to conduct clinical trials with its second novel Alzheimer compound, Bisnorcymserine